The price of PRGO is predicted to go up 5.3%, based on the high correlation periods with BIO. The similarity of these two price pattern on the periods is 90.89%.
PRGO
BIO
Perrigo is now more tapped in to the higher-margin branded consumer health market, and this should act as tailwind to the top and bottom lines in future.
Because of Perrigo's presence in private label, we think the company can more easily weather downturns compared with competitors that purely play in the branded market.
Perrigo's scale and ability to supply a wide range of private-label OTC products is unmatched by other smaller players, which partly protects the company's relationship with its customers.
Piper Sandler
2025-01-06
Price Target
$34 → $27
Upside
+6.64%
Jefferies
2024-09-23
Price Target
$50 → $30
Upside
+13.04%